CureVac

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CureVac and other ETFs, options, and stocks.

About CVAC

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy.

CEO

Alexander Zehnder

CEOAlexander Zehnder

Employees

983

Employees983

Headquarters

Tübingen, Baden Wuerttemberg

HeadquartersTübingen, Baden Wuerttemberg

Founded

2020

Founded2020

Employees

983

Employees983

CVAC Key Statistics

Market cap

790.12M

Market cap790.12M

Price-Earnings ratio

4.38

Price-Earnings ratio4.38

Dividend yield

—

Dividend yield—

Average volume

576.15K

Average volume576.15K

High today

$3.55

High today$3.55

Low today

$3.47

Low today$3.47

Open price

$3.48

Open price$3.48

Volume

25.01K

Volume25.01K

52 Week high

$5.28

52 Week high$5.28

52 Week low

$2.37

52 Week low$2.37

Analyst ratings

57%

of 7 ratings

Buy

57.1%

Hold

28.6%

Sell

14.3%

People also own

Based on the portfolios of people who own CVAC. This list is generated using Robinhood data, and it’s not a recommendation.

Virgin Galactic Holdings